Progress Software Corporation (PRGS) Jumps 5.79% on February 16

Equities Staff |

Progress Software Corporation (PRGS) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 5.79% to $23.76, representing a gain of $1.3 per share. Some 200,517 shares traded hands on 2,212 trades, compared with an average daily volume of 343,264 shares out of a total float of 50.91 million. The stock opened at $22.62 and traded with an intraday range of $23.99 to $22.62.

After today's gains, Progress Software Corporation reached a market cap of $1.21 billion. Progress Software Corporation has had a trading range between $30.57 and $21.94 over the last year, and it had a 50-day SMA of $23.97 and a 200-day SMA of $26.06.

Progress Software Corporation is a software company that simplifies the development, deployment and management of business applications on-premise or in the cloud, on any platform or device, and to any data source.

Progress Software Corporation is based out of Bedford, MA and has some 1,766 employees. Its CEO is Philip M. Pead.

For a complete fundamental analysis analysis of Progress Software Corporation, check out’s Stock Valuation Analysis report for PRGS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…